Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
222110
vs
K
KOSPI 200
Over the past 12 months, PanGen Biotech Inc has underperformed KOSPI 200, delivering a return of -31% compared to KOSPI 200's +56% growth.
Stocks Performance
222110 vs KOSPI 200
Performance Gap
222110 vs KOSPI 200
Performance By Year
222110 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PanGen Biotech Inc
Glance View
PanGen Biotech makes biological reagents and diagnostic products used in labs, hospitals, and research settings. Its main products include enzymes, molecular biology reagents, and test kits that help customers detect genes, study DNA, and run lab experiments. The company sells these products to diagnostic labs, biotech firms, research institutions, and other life-science customers that need reliable tools for testing and analysis. It earns money by selling its own products and by supplying materials that other companies use in their testing and manufacturing work. That means PanGen sits in the middle of the life-science supply chain: it does not just run tests itself, but provides the building blocks that make genetic testing and laboratory research possible. This makes the business more like a specialized tools supplier than a drug maker. What sets the company apart is its focus on the technical products behind molecular diagnostics and research, where consistency and performance matter a lot. Customers often buy from PanGen because they need specific enzymes, reagents, or kits that fit into their own workflows. In simple terms, PanGen Biotech sells the core lab ingredients that help other companies and institutions analyze DNA and run diagnostic tests.